A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response
Condition:   Respiratory Disorders Interventions:   Biological: NTHi Mcat investigational vaccine (GSK3277511A);   Biological: Placebo Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2017 Category: Research Source Type: clinical trials

A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response
Condition:   Respiratory Disorders Interventions:   Biological: NTHi Mcat investigational vaccine (GSK3277511A);   Biological: Placebo Sponsor:   GlaxoSmithKline Not yet recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2017 Category: Research Source Type: clinical trials